H. Nalçakan Et Al. , "Molecular Docking and in Silico ADMET Analyses of Novel Fedratinib Derivatives as Potent JAK2 Inhibitors," 8th International BAU Drug Design Congress , İstanbul, Turkey, pp.127, 2022
Nalçakan, H. Et Al. 2022. Molecular Docking and in Silico ADMET Analyses of Novel Fedratinib Derivatives as Potent JAK2 Inhibitors. 8th International BAU Drug Design Congress , (İstanbul, Turkey), 127.
Nalçakan, H., Kurtay, G., & Güngör, T., (2022). Molecular Docking and in Silico ADMET Analyses of Novel Fedratinib Derivatives as Potent JAK2 Inhibitors . 8th International BAU Drug Design Congress (pp.127). İstanbul, Turkey
Nalçakan, Harun, Gülbin Kurtay, And TUĞBA GÜNGÖR. "Molecular Docking and in Silico ADMET Analyses of Novel Fedratinib Derivatives as Potent JAK2 Inhibitors," 8th International BAU Drug Design Congress, İstanbul, Turkey, 2022
Nalçakan, Harun Et Al. "Molecular Docking and in Silico ADMET Analyses of Novel Fedratinib Derivatives as Potent JAK2 Inhibitors." 8th International BAU Drug Design Congress , İstanbul, Turkey, pp.127, 2022
Nalçakan, H. Kurtay, G. And Güngör, T. (2022) . "Molecular Docking and in Silico ADMET Analyses of Novel Fedratinib Derivatives as Potent JAK2 Inhibitors." 8th International BAU Drug Design Congress , İstanbul, Turkey, p.127.
@conferencepaper{conferencepaper, author={Harun Nalçakan Et Al. }, title={Molecular Docking and in Silico ADMET Analyses of Novel Fedratinib Derivatives as Potent JAK2 Inhibitors}, congress name={8th International BAU Drug Design Congress}, city={İstanbul}, country={Turkey}, year={2022}, pages={127} }